Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | HPGDS | O60760 | 3/20 | 0.53 |
| ▸ | CTSD | P07339 | 2/20 | 0.52 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.49 |
| ▸ | DAO | P14920 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | AURKA | O14965 | 1/20 | 0.47 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.47 |
| ▸ | PLK1 | P53350 | 1/20 | 0.47 |
| ▸ | MET | P08581 | 1/20 | 0.47 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.47 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17335718 | 0.89 | TSHR (0.57) | L3MBTL1TSHRKMT2AHPGDSCTSD | |
| SCHEMBL6565513 | 0.88 | CTSD (0.54) | L3MBTL1TSHRKMT2AHPGDSCTSD | |
| SCHEMBL12747582 | 0.84 | L3MBTL1 (0.62) | L3MBTL1TSHRKMT2ACTSDFFAR4 | |
| SCHEMBL6563104 | 0.84 | L3MBTL1 (0.62) | L3MBTL1TSHRKMT2AHPGDSCTSD | |
| Hydrochloric Acid SCHEMBL31346661 | 0.84 | L3MBTL1 (0.62) | L3MBTL1TSHRKMT2AHPGDSCTSD | |
| SCHEMBL1075209 | 0.83 | L3MBTL1 (0.66) | L3MBTL1TSHRKMT2ADAOPLK1 | |
| SCHEMBL21683299 | 0.83 | PLK1 (0.58) | TSHRKMT2AMAPTPOLBPLK1 | |
| SCHEMBL7116372 | 0.82 | L3MBTL1 (0.59) | L3MBTL1TSHRKMT2AFFAR4DAO | |
| SCHEMBL6985892 | 0.82 | L3MBTL1 (0.59) | L3MBTL1TSHRKMT2ACTSDDAO | |
| SCHEMBL12747584 | 0.81 | L3MBTL1 (0.57) | L3MBTL1CTSDFFAR4DAOTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107982266-B | Carbamate compounds and methods of making and using the same | H.隆德贝克有限公司 | 2021-07-30 | — | — | CN | disclosed |
| US-20040220411-A1 | Oxalic acid derivatives | MERCK PATENT GMBH (DE) | 2004-11-04 | — | — | US | disclosed |
| EP-1377543-A1 | OXALIC ACID DERIVATIVES | MERCK PATENT GmbH (DE) | 2004-01-07 | — | — | EP | disclosed |
| WO-2002083630-A1 | OXALIC ACID DERIVATIVES | MERCK PATENT GMBH (DE) | 2002-10-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040220411-A1 | Oxalic acid derivatives | F11, F2, F12 | L3MBTL1 2292/4885TSHR 2897/4885KMT2A 3745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.